All In Biotech

Free tool

FAERS Monitor: Eliquis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202155 or its brand name (Eliquis, Apixaban). Reports on generic versions are filed under their own applications.

Reports

280,966

Serious

210,870

75% of reports

Hospitalization

92,944

Death reported

40,921

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death25,095
  • dyspnoea13,002
  • fatigue12,518
  • off label use12,368
  • atrial fibrillation10,940
  • diarrhoea10,264
  • fall9,795
  • cerebrovascular accident9,076
  • dizziness9,007
  • nausea8,776
  • headache7,976
  • thrombosis7,555
  • asthenia6,556
  • pneumonia6,443
  • cardiac disorder6,260

Reports by year received

View as table
YearReports
20051
20072
20087
200920
201036
2011117
201226
20131,174
20143,800
20157,567
201612,344
201717,213
201821,671
201927,146
202030,826
202134,744
202229,838
202326,565
202426,750
202523,878
202617,241

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,773,193 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
atrial fibrillationSignal10,9409.39.272,713
thrombosisSignal7,5557.77.539,743
cardiac disorderSignal6,2605.35.220,445
cerebrovascular accidentSignal9,0764.24.120,951
fallSignal9,7952.22.26,626
deathSignal25,0952.22.216,950
dyspnoea13,0021.71.74,075
pneumonia6,4431.51.51,067
dizziness9,0071.41.3856
asthenia6,5561.31.3483
fatigue12,5181.21.2454
diarrhoea10,2641.21.2326
off label use12,3681.11.041
headache7,9761.00.920
nausea8,7760.80.8321

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.